RE:This company completely lost in focusActuarial wrote: The management just need to focus on Alz but not other short life projects, such as Covid-19, which best in class doesn't matter, first in class wins.
This is not slight on this intial post by Acturial, but an attempt to inform by presenting updated info ..
A very recent article in the NY Times that seems to confirm that best in class will be essential in getting all aspects of the community and economy back on track. We will see tests starting to come out everyday, they will be highlighted and also critiqued . I saw a special last night on CNN dealing exactly with these types of tests in Italy. The difference I anticipate seeing with Dr Cashman's test will be the efficiency of the tests that will make it the standout. Focus on the history and ability that PMN has on this kind of test. Also focus on the extreme need for this test.. example NY State and a few others that say they have to have an effective test to safely open up their communities.
:ink to NY Times ...
Antibody Test, Seen as Key to Reopening Country, Does Not Yet Deliver The tests, many made in China without F.D.A. approval, are often inaccurate. Some doctors are misusing them. The rollout is nowhere close to the demand.
https://www.nytimes.com/2020/04/19/us/coronavirus-antibody-tests.html